Curaleaf

Curaleaf Holdings, Inc. is a vertically integrated global cannabis company that cultivates, processes, manufactures, distributes, and sells cannabis products through both retail and wholesale channels. In the United States, the company serves both medical and adult-use cannabis markets across 15 states, operating 164 dispensaries, 18 manufacturing facilities, and 15 cultivation sites with approximately 1.5 million square feet of cultivation capacity. Revenue is generated primarily through direct-to-consumer retail sales (71% of total revenues) and wholesale channels (28%). Internationally, Curaleaf maintains cultivation operations in Portugal and Canada, pharma-grade EU-GMP certified processing and manufacturing in Germany, Spain, Canada, Portugal, and the U.K., and wholesale distribution to Australia, New Zealand, and several European countries including Germany, Poland, Switzerland, and the U.K. The company also operates a medical cannabis clinic and pharmacy in the U.K. Its brand portfolio includes Anthem, Curaleaf, Dark Heart, Find, Grassroots, JAMS, Reef, Select, Four20 Pharma, Green Britannia, and Huala. The company operates through two reportable segments: Domestic Operations and International Operations, with over 1,300 wholesale partner accounts in the U.S. As of May 1, 2026, the company had 93,970,705 multiple voting shares and 698,208,521 subordinate voting shares outstanding, along with 23,208,985 RSUs, 11,149,047 PSUs, and 27,209,340 stock options. Shares trade on the Toronto Stock Exchange under CURA and on the OTCQX Best Market under CURLF. Updated May 6, 2026